The heterogeneity of PRKCε expression among MD-OS tumors may indicate heterogeneous networks are aberrant in MD-OS tumors, or that the PRKCε-RASGRP3-GNB2 network may be disrupted through alterations of other genes in the network. The gene discussed is PRKCE; the disease is Menkes disease.